All News about Irhythm Technologies Inc
![](https://cdn.benzinga.com/files/images/story/2022/05/06/premkt_movers.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_6325.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/earnings_image_1817.jpeg)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/analyst_ratings_image_1460.jpeg?width=720)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_2366.png)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_6332.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/lab-5740505_1920_4.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/ep_us_feature_image_892.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/biotech7.jpg)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/analyst_ratings_image_1901.jpeg?width=720)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/analyst_ratings_image_1314.jpeg?width=720)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street.jpg)
![](https://investorplace.com/wp-content/uploads/2021/09/heart-diagram.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_368.png)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/analyst_ratings_image_4931.jpeg?width=720)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/analyst_ratings_image_4679.jpeg?width=720)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_2404.png)
![](https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template.jpg)
iRhythm Technologies Inc (IRTC) Q3 2021 Earnings Call Transcript
November 05, 2021
Via The Motley Fool
Topics
Earnings
Exposures
Financial
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/movers_image_3909.jpeg?width=720)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/city-g9f56a5765_1920.jpg)
![](https://g.foolcdn.com/editorial/images/650500/heart-monitoring-ecg.jpg)
Atrial Fibrillation Market Is Expected To Reach $11.123 Billion At A CAGR 11.2 % Through 2023
November 04, 2021
Topics
Death
Exposures
Death
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-afternoon-market-update_60.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_323.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/movers_image_3829.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-morning-market-update_59.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.